Partial versus radical nephrectomy for pT3a renal cell carcinoma: a systematic review and meta-analysis

pT3a期肾细胞癌的部分肾切除术与根治性肾切除术:系统评价和荟萃分析

阅读:1

Abstract

The surgical management of pathologic T3a (pT3a) renal cell carcinoma (RCC) remains contentious due to the lack of high-level evidence guiding the choice between partial nephrectomy (PN) and radical nephrectomy (RN). This systematic review and meta-analysis aims to evaluate whether PN represents a safe and effective alternative to RN. A comprehensive search of PubMed, Web of Science, and Scopus was conducted through July 2025. The study included comparative trials of adult pT3a RCC patients undergoing PN or RN, focusing on oncological, perioperative, and functional outcomes. Sixteen retrospective studies involving 34,304 patients (5878 PN; 28426 RN) were analyzed. There were no statistically significant differences between PN and RN regarding estimated blood loss, operative time, hospital stay, or major postoperative complications (Clavien-Dindo > 2). PN was associated with significantly better preservation of renal function (9.96; I(2) 0%; p < 0.01), higher rate of positive surgical margins (0.82; I(2) 49.2%; p < 0.01), lower tumor size (-2.6; I(2) 99.4%; p < 0.01). PN is a safe and feasible alternative for pT3a RCC cases, providing superior functional preservation without compromising perioperative safety or oncological control. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11701-026-03384-8.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。